An important reference which provides an overview of the current and recently introduced methodologies for testing the immunotoxic risks in drug candidates
Helps readers understand the significance of the methods and approaches to immunotoxicology testing
Aids drug scientists in industry and regulatory areas to consolidate approaches to immunotox testing
Offers a definitive assessment of nonclinical models to study the toxic impacts (bio)pharmaceuticals can have on the immune system
Includes chapter authors from across the pharma industry, bringing a real-world and applied perspective to immunotox testing
About the Author
Danuta Herzyk is the Senior Scientific Director in the Safety Assessment department of Merck Research Laboratories. Prior to that, she worked in Immunologic Toxicology for GlaxoSmithKline. A member of the Society of Toxicology, Drug Information Association, and American Association of Immunologists, Dr. Herzyk has published 38 articles and 42 abstracts and is also on the editorial board of Perspectives in Experimental and Clinical Immunotoxicology.
Jeanine Bussiere is the Director of Toxicology for Amgen. She is on the editorial board of Journal of Immunotoxicology and was Planner and Lecturer for a 2004-5 course at the University of Wisconsin-Madison called “Introduction to Drug Development.” Dr. Bussiere is a member of the Society of Toxicology, American College of Toxicology, and Drug Information Association. She is the author or co-author of 8 book chapters and 49 articles.
